Losing hair can hurt in its own right. People describe feeling self-conscious, anxious or low, and some find the worry itself becomes the bigger problem. This guide looks at what the research says about hair loss and mood, why it cannot say which causes which, what the NHS suggests, and what to tell a prescriber if you are thinking about treatment.
If you are struggling with your mood right now, you can call Samaritans free on 116 123 at any time, call NHS 111, or call 999 or go to A&E if you feel at risk of serious harm.
If your main question is whether stress can cause shedding, and how long it takes, see does stress cause hair loss? This article is about the other direction: what hair loss does to how you feel.
What the research found
A 2025 case-control study in the European Journal of Dermatology (Fişek Izci and others) compared 205 people with telogen effluvium with 105 healthy controls. It found higher perceived stress, anxiety and depression scores in the telogen effluvium group, and lower quality of life.
That is a real finding, but it is easy to over-read:
- It shows an association. The two go together. It does not show which causes which. Stress can trigger shedding, and shedding can cause stress.
- It studied one type of hair loss. Telogen effluvium is temporary, widespread shedding. The study does not tell us how people with other kinds of hair loss feel.
- It is one study. A sample of 310 people, in one setting, cannot describe everyone.
A 2026 review in the Cleveland Clinic Journal of Medicine describes the triggers of telogen effluvium as physiological or emotional stressors, such as illness, surgery, childbirth, nutritional deficiencies, medicines or infection, and notes that a cause cannot always be found. The British Association of Dermatologists (BAD) gives the same picture: for 1 in 3 people with telogen effluvium, “no cause can be found”.
Why the link runs both ways
The BAD says telogen effluvium can start around 3 months after a trigger, such as a stressful life event, so the shedding often arrives long after the event that set it off. That delay can leave people searching for a cause and, in the meantime, watching their hair thin. Our telogen effluvium condition page and the hair growth cycle entry explain the mechanism.
The BAD says shedding typically lasts 3 to 6 months, usually gets better without treatment, and that it “may take many months for your hair to return to normal volume and thickness”. Waiting through that stretch is hard. It is not a sign that you are coping badly.
Stress does not cause the gradual, inherited thinning known as pattern hair loss, although the two can appear together. The BAD says “sometimes both of these conditions appear around the same time”. A doctor can help tell them apart, and the answer changes what is worth doing.
What the NHS suggests
The NHS says to see a GP if you are struggling to cope with stress, and that adults can refer themselves to NHS talking therapies without a GP. The NHS also says a GP can talk to you about how hair loss is affecting you. Hair loss that is affecting your wellbeing is a reasonable thing to raise.
Practical steps that fit what the BAD says about telogen effluvium:
- Ask for the reversible causes to be checked. A blood test can check for iron deficiency or a thyroid problem. Our sister service WMG Health explains which tests are used for stress-related hair loss; a blood test is information, not a diagnosis.
- Be gentle with your hair. Avoid harsh brushing, limit heated tools and tight hairstyles.
- Look after the basics. The BAD says food rich in iron, protein, fruit and vegetables “may be helpful”, and advises stopping smoking, since cigarette smoke can worsen hair loss.
- Consider camouflage. Hair fibre powders or sprays and volumising shampoo can help while hair recovers.
If you are thinking about treatment
Telogen effluvium is not treated with prescription medicines, and the BAD says “medication does not speed up hair regrowth”. If a doctor decides your thinning is, or includes, pattern hair loss, treatment may be an option, and mood matters to that decision.
Finasteride 1 mg is licensed in the UK for the treatment of men with male pattern hair loss (androgenetic alopecia). In 2024 the MHRA told prescribers to “ask patients if they have a history of depression or suicidal ideation” before prescribing, and to monitor for psychiatric and sexual side effects. On 11 May 2026 the MHRA said finasteride “is associated with depression, suicidal ideation and sexual dysfunction which may persist after treatment is stopped”. If you develop depression or suicidal thoughts on finasteride 1 mg, the MHRA advice is to stop it immediately and contact your doctor as soon as possible. Read our guide to the MHRA warnings.
So if you already feel low or anxious about your hair, say so at your assessment. It is information a prescriber needs, not something that disqualifies you. At WMG Meds, a GMC-registered doctor reviews your questionnaire, asks about your mood history, and may decide treatment is not appropriate, in which case they will tell you why. Topical minoxidil prepared by WMG Meds is an unlicensed special, prescribed off-label after an individual clinical assessment.
When to see a doctor
See a doctor if:
- your mood is low, or your worry about your hair is taking over your days
- shedding is not getting better. The BAD recommends this “to rule out other causes of hair loss”
- shedding has lasted more than 6 months
- you notice smooth bald patches. The BAD describes alopecia areata as one or more smooth patches that “are not inflamed or scaly”. See alopecia areata
- you also feel unusually tired, cold or breathless. The NHS lists hair loss among symptoms of iron deficiency anaemia and of an underactive thyroid
If you are unsure what kind of hair loss you have, you can start a clinical review. A GMC-registered doctor will tell you if treatment is not appropriate and, where relevant, point you to your GP.
Related reading
- Seasonal hair shedding: what the evidence shows: The seasonal shedding evidence, if the timing of your shedding is the question.
- Hair loss in your 20s and 30s: what to check: A checklist of causes and checks if you are losing hair in your 20s or 30s.
- Hair loss in the New Year: what a doctor checks: What a doctor asks, examines and tests first.
- What happens in an online hair loss consultation: What to expect from an online consultation.
- Finasteride side effects: what the MHRA says: The overview of finasteride side effects, with every symptom guide.
Frequently asked questions
Can hair loss cause anxiety or depression?
A 2025 study found higher anxiety and depression scores in people with telogen effluvium than in healthy controls, but it shows an association, not which causes which. Speak to your GP if hair loss is affecting your mood.
Will my hair grow back?
Usually, yes, for telogen effluvium. The BAD says it typically gets better without treatment, but regrowth can take many months. If an underlying cause such as iron deficiency is not dealt with, shedding can return.
Where can I get support?
Your GP, NHS talking therapies (you can refer yourself), NHS 111, and Samaritans on 116 123 at any time. Call 999 or go to A&E if you feel at risk of serious harm.
How do I report a side effect from a medicine?
Tell your prescriber. You can also report suspected side effects to the MHRA through the Yellow Card scheme.
Sources
- British Association of Dermatologists, Telogen effluvium: patient information leaflet, updated October 2025
- British Association of Dermatologists, Hair loss in men: male pattern (androgenetic alopecia), updated June 2024
- British Association of Dermatologists, Alopecia areata, updated April 2024
- NHS, Hair loss, last reviewed 24 January 2024
- NHS, Iron deficiency anaemia and Underactive thyroid: symptoms
- NHS, Stress, last reviewed 6 March 2026
- Bergfeld WF, Mendez D. Shedding: an updated guide to a common cause of hair loss. Cleveland Clinic Journal of Medicine, 2026 (PubMed 42823125)
- Fişek Izci N and others. Significant impact of telogen effluvium on quality of life, depression, anxiety and stress. European Journal of Dermatology, 2025 (PubMed 40965527)
- MHRA Drug Safety Update, 29 April 2024: Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects
- MHRA Drug Safety Update, 11 May 2026: Finasteride and Dutasteride: updated safety warnings
- Propecia 1 mg film-coated tablets: summary of product characteristics, emc, revised 29 June 2026
- Yellow Card scheme, MHRA
- Samaritans: contact us
- NHS: where to get urgent help for mental health